JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5501
Atossa Therapeutics
ATOS
$22.7M
| $64.3K | ﹤0.01% |
3,600
+3,594
| +59,900% | +$79.5K |
2021 Q2
12 quarters
|
|
5502
iShares MSCI France ETF
EWQ
$342M
| $64.1K | ﹤0.01% |
1,697
+478
| +39% | +$19.4K |
2022 Q3
7 quarters
|
|
5503
Urban One Class A
UONE
$18.6M
| $63.9K | ﹤0.01% |
3,210
+1,125
| +54% | +$24.4K |
2022 Q2
8 quarters
|
|
5504
Contango Silver & Gold Inc
CTGO
$563M
| $63.8K | ﹤0.01% |
3,528
+288
| +9% | +$5.86K |
2021 Q4
10 quarters
|
|
5505
Senseonics Holdings Inc
SENS
$527M
| $63.7K | ﹤0.01% |
7,986
+7,255
| +992% | +$64.6K |
2017 Q4
26 quarters
|
|
5506
CALL
Upstart Holdings
UPST
$2.23B
| $63.7K | ﹤0.01% |
2,700
+1,200
| +80% | +$29K |
2023 Q3
3 quarters
|
|
5507
NLI Holdings
NL
$346M
| $63.6K | ﹤0.01% |
10,542
-9,111
| -46% | -$68K |
2016 Q4
30 quarters
|
|
5508
Foghorn Therapeutics
FHTX
$173M
| $63.6K | ﹤0.01% |
11,053
-2,985
| -21% | -$17.8K |
2020 Q4
14 quarters
|
|
|
FFNW
5509
DELISTED
First Financial Northwest, Inc
FFNW
| $63.3K | ﹤0.01% |
2,996
-2,353
| -44% | -$48.8K |
2016 Q4
30 quarters
|
|
5510
PUT
Azenta
AZTA
$1.51B
| $63.1K | ﹤0.01% |
1,200
| – | – |
2024 Q1
1 quarter
|
|
5511
Verrica Pharmaceuticals
VRCA
$82.4M
| $63.1K | ﹤0.01% |
865
-10
| -1% | -$768 |
2018 Q3
23 quarters
|
|
5512
Hamilton Beach Brands
HBB
$499M
| $63.1K | ﹤0.01% |
3,668
-7,465
| -67% | -$152K |
2017 Q4
26 quarters
|
|
5513
Fennec Pharmaceuticals
FENC
$362M
| $63K | ﹤0.01% |
10,314
+491
| +5% | +$4.08K |
2021 Q4
10 quarters
|
|
5514
Innovator US Equity Power Buffer ETF November
PNOV
$862M
| $63K | ﹤0.01% |
1,735
+616
| +55% | +$22.1K |
2024 Q1
1 quarter
|
|
|
BPT
5515
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $62.8K | ﹤0.01% |
+25,442
| New | +$61.4K |
2024 Q2
0 quarters
|
|
|
BRACR
5516
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
| $62.5K | ﹤0.01% |
305,275
| – | – |
2023 Q4
2 quarters
|
|
5517
CPI Card Group
PMTS
$286M
| $62.2K | ﹤0.01% |
2,283
+455
| +25% | +$10.3K |
2022 Q4
6 quarters
|
|
5518
CALL
Extra Space Storage
EXR
$28.1B
| $62.2K | ﹤0.01% |
+400
| New | +$58.3K |
2024 Q2
0 quarters
|
|
|
5519
PUT
Extra Space Storage
EXR
$28.1B
| $62.2K | ﹤0.01% |
+400
| New | +$58.3K |
2024 Q2
0 quarters
|
|
5520
PUT
Legend Biotech
LEGN
$3.76B
| $62K | ﹤0.01% |
1,400
| – | – |
2023 Q4
2 quarters
|
|
5521
Medallion Financial
MFIN
$274M
| $61.9K | ﹤0.01% |
8,064
-38,764
| -83% | -$307K |
2019 Q1
21 quarters
|
|
5522
Crawford & Co Class A
CRD.A
$598M
| $61.6K | ﹤0.01% |
7,124
+1,279
| +22% | +$11.9K |
2019 Q1
21 quarters
|
|
|
ADVM
5523
DELISTED
Adverum Biotechnologies
ADVM
| $61.1K | ﹤0.01% |
8,904
+8,866
| +23,332% | +$82.4K |
2014 Q3
39 quarters
|
|
5524
QuickLogic
QUIK
$214M
| $61.1K | ﹤0.01% |
5,877
+1,787
| +44% | +$22.5K |
2023 Q4
2 quarters
|
|
5525
InfuSystem Holdings
INFU
$255M
| $61K | ﹤0.01% |
8,933
-6,803
| -43% | -$50K |
2020 Q2
16 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.